Invesco Mutual Fund has announced the launch of the Invesco India Pharma and Healthcare Fund, an open-ended equity scheme focused on companies operating across the pharmaceutical, healthcare and allied sectors.

The new fund aims to tap into India’s expanding healthcare ecosystem, supported by favourable demographics, rising healthcare spending, greater insurance penetration, growing global pharmaceutical leadership and increasing innovation across healthcare and life sciences.

The scheme will invest across a broad range of healthcare segments, including pharmaceuticals, hospitals, diagnostics, contract development and manufacturing organisations (CDMOs), contract research organisations (CROs), medical devices, healthcare services, insurance and other allied businesses.

According to Invesco, India’s large talent pool, manufacturing capabilities, healthcare infrastructure and growing innovation ecosystem position the country favourably within the global healthcare landscape. 

Rising healthcare expenditure, ageing demographics, increasing incidence of lifestyle-related diseases, expanding health insurance coverage and growing global outsourcing are expected to create long-term opportunities across the sector.

The fund will be managed by Aditya Khemani, Head of Equity & Fund Manager, Invesco Mutual Fund, and will be benchmarked against the BSE Healthcare TRI.

Khemani said India’s healthcare sector is undergoing a structural transformation, driven by rising healthcare consumption as well as the country’s growing role as a global pharmaceutical and healthcare innovation hub.

He added that the fund will seek opportunities across domestic pharmaceuticals, hospitals, diagnostics, CDMOs and emerging healthcare segments, with a focus on identifying quality businesses with sustainable competitive advantages and strong growth visibility.

The New Fund Offer (NFO) opened for subscription on August 18, 2026, and will close on September 1, 2026.

The minimum lumpsum investment during the NFO is Rs. 1,000, with additional investments in multiples of Rs. 1. For SIP investments, the minimum application amount is Rs. 100, also in multiples of Rs. 1.

The scheme will levy an exit load of 0.50% on units redeemed or switched out within three months of allotment. No exit load will apply to redemptions or switches made after three months.